CN101366904B - Externally used plaster for treating gland hyperplasia - Google Patents

Externally used plaster for treating gland hyperplasia Download PDF

Info

Publication number
CN101366904B
CN101366904B CN2008101575509A CN200810157550A CN101366904B CN 101366904 B CN101366904 B CN 101366904B CN 2008101575509 A CN2008101575509 A CN 2008101575509A CN 200810157550 A CN200810157550 A CN 200810157550A CN 101366904 B CN101366904 B CN 101366904B
Authority
CN
China
Prior art keywords
radix
grams
plaster
root
cyclomastopathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101575509A
Other languages
Chinese (zh)
Other versions
CN101366904A (en
Inventor
柏建军
卢春丽
崔成昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101575509A priority Critical patent/CN101366904B/en
Publication of CN101366904A publication Critical patent/CN101366904A/en
Application granted granted Critical
Publication of CN101366904B publication Critical patent/CN101366904B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine, in particular an external plaster for treating hyperplasia of mammary glands. The external plaster for treating hyperplasia of mammary glands is characterized in that the plaster is made by the following crude drugs: angelica, chuanxiong rhizome, white peony root, dahurian angelica root, bicolor lespedeza, forsythia fruit, rhubarb, Chinese gall, semen momordicae, eucommia, boswellin, myrrh, cortex moutan, honeysuckle, radix scutellariae, radix rehmanniae, safflower, scrophularia, Sichuan fritillary bulb, pangolin scales, rubefacient, borneol, musk, membrane of hen egg, Panax pseudo-ginseng and licorice root. The plaster which adopts traditional Chinese medicines as raw materials and does no harm to a human body has the advantages of remarkable effect and high curative rate.

Description

A kind of externally applied ointment for the treatment of cyclomastopathy
(1) technical field
The present invention relates to a kind of medicine, particularly a kind of externally applied ointment for the treatment of cyclomastopathy.
(2) background technology
The treatment cyclomastopathy is with periodically disorder of hormone secretion or mammary gland tissue sensitivity increase relevant, at present increasing women is subjected to the puzzlement of cyclomastopathy, the traditional Chinese medical science does not have unified Therapeutic Method, and what it is generally acknowledged cyclomastopathy is deficiency of kidney-QI at all, fill the post of imbalance.Method such as adopt dispersing the stagnated live-QI to relieve the stagnation of QI, blood circulation promoting and blood stasis dispelling, the kidney invigorating to transfer to fill in the treatment, or a method single with or the number method share, effect is unsatisfactory, and Western medicine process internal organs can cause certain side effect to health.
(3) summary of the invention
The present invention is in order to remedy the deficiencies in the prior art, the invention provides a kind of externally applied ointment of treatment cyclomastopathy evident in efficacy.
The present invention is achieved through the following technical solutions:
A kind of externally applied ointment for the treatment of cyclomastopathy is characterized in that: be to be made by the crude drug of following parts by weight:
Radix Angelicae Sinensis 9-15 part Rhizoma Chuanxiong 10-18 part Radix Paeoniae Alba 6-12 part Radix Angelicae Dahuricae 8-14 part
Fructus Gardeniae 10-15 part Fructus Forsythiae 15-20 part Radix Et Rhizoma Rhei 9-15 part Galla Chinensis 10-20 part
Semen Momordicae 12-18 part Cortex Eucommiae 9-15 part Olibanum 15-20 part Myrrha 15-20 part
Cortex Moutan 9-14 part Flos Lonicerae 20-35 part Radix Scutellariae 8-15 part Radix Rehmanniae 9-20 part is red
Flower 10-15 part Radix Scrophulariae 10-15 part Bulbus Fritillariae Cirrhosae 15-20 part Squama Manis 10-20 part
Radix Polygoni Ciliinerve 9-15 part Borneolum Syntheticum 15-20 part Moschus 3-5 part Membrana Follicularis ovi 6-12 part
Typhonium flagelliforme (Lodd.) Blume 15-20 part Radix Glycyrrhizae 12-30 part.
Manufacture method of the present invention is as follows:
Earlier the medical material for preparing is put in the iron pan, pours Oleum sesami into, about half an hour at a simmer, pour out medicinal liquid, remove medicinal residues, oil droplet becomes droplet, adds one jin of Plumbum preparatium, and medicinal liquid is black, pours in the cold water after the cooling, pulls out water is extruded, and packing can be used.
Drug main of the present invention will be used for the treatment of: innominate toxic swelling, fibroma, benign tumor, cyclomastopathy, cyclomastopathy, mastitis, parotitis and various inflammation.
Usage and dosage: 1, with the illing skin cleaning surfaces, dry; 2, the low temperature baking is soft, is affixed on the affected part; 3, paste preceding elder generation ointment is smoked soft degree, involutory slide is changeed, and messenger drug enlarges slightly with area, pastes usefulness then, and available cloth swathes in case move.
Points for attention: 1, anemia of pregnant woman's forbidding, local skin breakage or suppuration person's forbidding, bleeding tendency person's forbidding, the careful usefulness of allergic constitution person; 2, occurring skin after pasting and itch or bear red granules, is that the efficacy of a drug is infiltrated due to the focus chafe, and plaster is temporarily thrown off, and flicks with hot towel, is sure not to scratch, waiting itches end after subsides again; 3, lose money in a business general equal behind the plaster can be in recovery from illness unconsciously, but more phenomenons such as pain, sourer or livid purple redness of chronognosis affected part are arranged, this is the efficacy of a drug phenomenon that source of disease outwards disperses of will hiding, soon can alleviate, meeting this situation please don't be alarmed 4, paste and take other pill wine simultaneously with this plaster and loose and does not all have obstructions, but the pungent irritable food of must avoiding cold and uncooked food, and the palpus attention is maintained, do not have a cold, do not soak cold water, keep happy.
The clinical observation of medicine of the present invention:
(1) physical data:
The inventor in nineteen ninety so far, 156 routine patients are carried out clinical observation treatment.Age 18 is to 66 years old, cyclomastopathy 89 examples wherein, cyclomastopathy 23 examples, mastitis 21 examples, fibroma 12 examples, unknown malignant tumor 6 examples, parotitis 5 examples.
(2) Therapeutic Method:
Plaster of the present invention is affixed on the affected part, the sustainable release of the efficacy of a drug 5 to 7 days, and above-mentioned focus three to seven is pasted and is got final product.
(3) efficacy assessment standard:
The present invention as efficacy assessment standard, is divided into following three kinds with every doing well,improving situation:
Cure: clinical symptoms and sign all disappear, and efficacy consolidation.
Effectively: clinical symptoms and sign make moderate progress.
Invalid: no change before the treatment.
(4) therapeutic effect:
Clinical observation statistical result
Figure 66871DEST_PATH_GSB00000274085800021
Brief summary: through the clinical treatment observation that 156 routine patients are carried out, 1 month to 3 months treatment phase, the patient cures 148 examples, effective 5 examples, and effective percentage 94.9%, cure rate 98.1% has notable therapeutic effect.
It is raw material that the present invention selects Chinese medicine for use, to the human body nonhazardous, has that effect is remarkable, cure rate is high, is difficult for recurrence, few advantage of spending.
(4) specific embodiment
Embodiment 1:
Get the crude drug of following weight:
Radix Angelicae Sinensis 9 grams, Rhizoma Chuanxiong 10 grams, the Radix Paeoniae Alba 6 grams, the Radix Angelicae Dahuricae 8 grams, Fructus Gardeniae 10 grams, Fructus Forsythiae 15 grams, Radix Et Rhizoma Rhei 9 grams, Galla Chinensis 10 grams, Semen Momordicae 12 grams, the Cortex Eucommiae 9 grams, Olibanum 15 grams, Myrrha 15 grams, Cortex Moutan 9 grams, Flos Lonicerae 20 grams, Radix Scutellariae 8 grams, the Radix Rehmanniae 9 grams, Flos Carthami 10 grams, Radix Scrophulariae 10 grams, Bulbus Fritillariae Cirrhosae 15 grams, Squama Manis 10 grams, Radix Polygoni Ciliinerve 9 grams, Borneolum Syntheticum 15 grams, Moschus 3 grams, Membrana Follicularis ovi 6 grams, Typhonium flagelliforme (Lodd.) Blume 15 grams, Radix Glycyrrhizae 12 grams, earlier the medical material for preparing is put in the iron pan, pour Oleum sesami into, about half an hour at a simmer, pour out medicinal liquid, remove medicinal residues, oil droplet becomes droplet, add Plumbum preparatium 500 grams, medicinal liquid is black, after pouring in the cold water cooling into, pull out water is extruded, packing can be used, sustainable 5 to 7 days of the efficacy of a drug, and focus 3 to 7 is pasted and is got final product.
Embodiment 2:
Get the crude drug of following weight:
Radix Angelicae Sinensis 15 gram, Rhizoma Chuanxiong 18 grams, the Radix Paeoniae Alba 12 grams, the Radix Angelicae Dahuricae 14 grams, Fructus Gardeniae 15 grams, Fructus Forsythiae 20 grams, Radix Et Rhizoma Rhei 15 grams, Galla Chinensis 20 grams, Semen Momordicae 18 grams, the Cortex Eucommiae 15 grams, Olibanum 20 grams, Myrrha 20 grams, Cortex Moutan 14 grams, Flos Lonicerae 35 grams, Radix Scutellariae 15 grams, the Radix Rehmanniae 20 grams, Flos Carthami 15 grams, Radix Scrophulariae 15 grams, Bulbus Fritillariae Cirrhosae 20 grams, Squama Manis 20 grams, Radix Polygoni Ciliinerve 15 grams, Borneolum Syntheticum 20 grams, Moschus 5 grams, Membrana Follicularis ovi 12 grams, Typhonium flagelliforme (Lodd.) Blume 20 grams, Radix Glycyrrhizae 30 gram, manufacture method and consumption are identical with embodiment 1.
Embodiment 3:
Get the crude drug of following weight:
Radix Angelicae Sinensis 12 gram, Rhizoma Chuanxiong 15 grams, the Radix Paeoniae Alba 10 grams, the Radix Angelicae Dahuricae 10 grams, Fructus Gardeniae 10 grams, Fructus Forsythiae 18 grams, Radix Et Rhizoma Rhei 12 grams, Galla Chinensis 15 grams, Semen Momordicae 15 grams, the Cortex Eucommiae 12 grams, Olibanum 18 grams, Myrrha 18 grams, Cortex Moutan 12 grams, Flos Lonicerae 25 grams, Radix Scutellariae 13 grams, the Radix Rehmanniae 16 grams, Flos Carthami 12 grams, Radix Scrophulariae 12 grams, Bulbus Fritillariae Cirrhosae 18 grams, Squama Manis 16 grams, Radix Polygoni Ciliinerve 13 grams, Borneolum Syntheticum 18 grams, Moschus 4 grams, Membrana Follicularis ovi 9 grams, Typhonium flagelliforme (Lodd.) Blume 18 grams, Radix Glycyrrhizae 16 gram, manufacture method and consumption are identical with embodiment 1.

Claims (1)

1. externally applied ointment for the treatment of cyclomastopathy is characterized in that: be to be made by the crude drug of following parts by weight:
Radix Angelicae Sinensis 9-15 part Rhizoma Chuanxiong 10-18 part Radix Paeoniae Alba 6-12 part
Radix Angelicae Dahuricae 8-14 part Fructus Gardeniae 10-15 part Fructus Forsythiae 15-20 part
Radix Et Rhizoma Rhei 9-15 part Galla Chinensis 10-20 part Semen Momordicae 12-18 part
Cortex Eucommiae 9-15 part Olibanum 15-20 part Myrrha 15-20 part
Cortex Moutan 9-14 part Flos Lonicerae 20-35 part Radix Scutellariae 8-15 part
Radix Rehmanniae 9-20 part Flos Carthami 10-15 part Radix Scrophulariae 10-15 part
Bulbus Fritillariae Cirrhosae 15-20 part Squama Manis 10-20 part Radix Polygoni Ciliinerve 9-15 part
Borneolum Syntheticum 15-20 part Moschus 3-5 part Membrana Follicularis ovi 6-12 part
Typhonium flagelliforme (Lodd.) Blume 15-20 part Radix Glycyrrhizae 12-30 part.
CN2008101575509A 2008-10-07 2008-10-07 Externally used plaster for treating gland hyperplasia Expired - Fee Related CN101366904B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101575509A CN101366904B (en) 2008-10-07 2008-10-07 Externally used plaster for treating gland hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101575509A CN101366904B (en) 2008-10-07 2008-10-07 Externally used plaster for treating gland hyperplasia

Publications (2)

Publication Number Publication Date
CN101366904A CN101366904A (en) 2009-02-18
CN101366904B true CN101366904B (en) 2011-01-19

Family

ID=40410996

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101575509A Expired - Fee Related CN101366904B (en) 2008-10-07 2008-10-07 Externally used plaster for treating gland hyperplasia

Country Status (1)

Country Link
CN (1) CN101366904B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104306478A (en) * 2014-10-08 2015-01-28 张旭 Medicine for treating mastitis and preparation method of medicine
CN106138562A (en) * 2015-06-04 2016-11-23 邹祥福 A kind of mammary gland patch medicine and preparation method thereof
CN109125430A (en) * 2018-11-23 2019-01-04 张瑞武 A kind of external medicine composition for cancer pain

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1335143A (en) * 2000-07-21 2002-02-13 梁永明 Chinese medicine for treating mastoproliferation
CN1528411A (en) * 2003-10-06 2004-09-15 刘善生 External plaster for treating mammary gland proliferation, mammary lobe proliferation and mammary cystic proliferation
CN1883600A (en) * 2005-06-20 2006-12-27 汤玉龙 Traditional Chinese medicinal ointment for treating mammary gland hyperplasia

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1335143A (en) * 2000-07-21 2002-02-13 梁永明 Chinese medicine for treating mastoproliferation
CN1528411A (en) * 2003-10-06 2004-09-15 刘善生 External plaster for treating mammary gland proliferation, mammary lobe proliferation and mammary cystic proliferation
CN1883600A (en) * 2005-06-20 2006-12-27 汤玉龙 Traditional Chinese medicinal ointment for treating mammary gland hyperplasia

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
化玉梅等.消癖散结膏治疗乳腺增生36例.《中国民间疗法》.2000,第8卷(第4期),第33页. *
王惟恒.乳腺增生病的中医外治法.《中国中医药报》.2002, *
魏述炎等.膏药外贴配合手法治疗乳腺增生18例.《中医外治杂志》.2004,第13卷(第1期),第27页. *

Also Published As

Publication number Publication date
CN101366904A (en) 2009-02-18

Similar Documents

Publication Publication Date Title
CN102430099B (en) Life-prolonging essence
CN100509014C (en) Medicament for treating mammitis
CN101411848B (en) Black plaster for treating gland hyperplasia and preparation method thereof
CN102309699A (en) Traditional Chinese medicine (TCM) prescription for treating cervical cellulitis
CN101371914A (en) Chinese medicine health-care brassiere
CN102188583A (en) Traditional Chinese medicine for treating infertility
CN100398141C (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN102038911A (en) Traditional Chinese medicine preparation for treating acute mastitis
CN103393989B (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN102688387B (en) Medicine for treating subacute thyroiditis
CN101366904B (en) Externally used plaster for treating gland hyperplasia
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN103585591A (en) Traditional Chinese medicine for treating gallstones
CN102451378A (en) Uterus health capsule for treating gynopathy
CN102205096B (en) Medicament for treating adnexitis and pelvic inflammation
CN102151324A (en) Chinese medicine preparation for treating female infertility in childbearing peroid of right age
CN104887893B (en) A kind of external application Chinese medicine and application method for treating gynaecology's dysmenorrhoea disease
CN103520354B (en) Traditional Chinese medicine for treatment of blood-insufficiency type mammary gland hyperplasia and preparation method thereof
CN103341025B (en) Traditional Chinese medicine composition for treating premature ejaculation
CN101518639B (en) Drug for treating acne
CN100389815C (en) Medicine for treating mammary glands hyperplasia
CN101530596B (en) Capsule for treating mammary gland diseases and preparation method thereof
CN105748814A (en) Traditional Chinese medicine composition for treating amenorrhea
CN103585358A (en) Mastitis treatment anti-inflammation and swelling subsiding oral liquid and preparation method thereof
CN101966329A (en) Medicament for treating rash

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Bai Jianjun

Inventor after: Lu Chunli

Inventor after: Cui Chengchang

Inventor before: Bai Jianjun

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: BO JIANJUN TO: BO JIANJUN LU CHUNLI CUI CHENGCHANG

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110119

Termination date: 20111007